News | Oncology Information Management Systems (OIMS) | September 11, 2017

Provision Healthcare Joins RayCare Clinical Partners

Tennessee cancer network will add expertise in proton therapy to development of next-generation oncology information system

Provision Healthcare Joins RayCare Clinical Partners

September 11, 2017 — Provision, located in Knoxville, Tenn., is the latest to partner with RaySearch Laboratories on the development of its next-generation oncology information system (OIS), RayCare.

The global association of RayCare clinical partners now consists of, in order of entry:

  • UMC Groningen (Groningen, the Netherlands);
  • Iridium Kankernetwerk (Belgium);
  • The University of California San Francisco (UCSF);
  • MD Anderson Cancer Center (Houston);
  • University of Wisconsin–Madison; and
  • Provision CARES Proton Therapy Centers.

RaySearch’s clinical partners play a central role in the development of RayCare. They provide input on what an OIS should provide for various types of treatments, for different roles within healthcare teams and, ultimately, for patients. This input feeds into RaySearch’s development process, and new software versions are regularly provided to the partners so they can provide feedback on the implementation.

The RayCare clinical partners encompass different types of cancer care providers. Provision brings a strong focus on developing, managing and operating comprehensive cancer centers featuring proton therapy, bringing know-how needed to provide the highest possible quality of cancer care.

Niek Schreuder, vice president and chief medical physicist for Provision Healthcare, says: “For Provision, it is of great strategic importance for our Cancer CARE Network to have an integrated and efficient solution for patient treatment and care. RaySearch has the competence and innovative focus that Provision needs, and we share a vision of the future of cancer care.”

RayCare integrates the high-performance radiation therapy algorithms available in RayStation treatment planning system and adds advanced features for clinical resource optimization, workflow automation and adaptive radiation therapy.

Read the article "Oncology Information Systems Need to Integrate."

For more information: www.raysearchlabs.com

Related Content

Videos | Radiation Therapy | February 15, 2019
ITN Associate Editor Jeff Zagoudis speaks with Vinai Gondi, M.D., director of research and CNS neuro-oncology at the
New Targeted Therapy for Recurrent Brain Tumors Implanted for First Time
News | Radiation Therapy | February 15, 2019
University of Minnesota Health (M Health) is the first in the United States to begin offering GammaTile Therapy, a new...
Canon Adds Radiation Therapy Package to Aquilion Prime, Lightning CT Systems
News | Computed Tomography (CT) | February 11, 2019
In the patient-centric world of radiation oncology, it is critical that computed tomography (CT) simulation is...
Elekta Unity MR-Linac Earns FDA Clearance
Technology | Image Guided Radiation Therapy (IGRT) | February 07, 2019
The Elekta Unity magnetic resonance radiation therapy (MR/RT) system recently received 510(k) premarket notification...
University of Oklahoma Cancer Center Begins First Proton Therapy Treatments
News | Proton Therapy | February 01, 2019
Home to the largest and most comprehensive radiation therapy program in Oklahoma, the Stephenson Cancer Center at OU (...
Stereotactic Radiotherapy Improves Long-Term Survival in Stage-IV Cancers
News | Stereotactic Body Radiation Therapy (SBRT) | January 31, 2019
The first report from a phase II, multi-center clinical trial indicates stereotactic radiation can extend long-term...
Philips Collaborates With MIM Software on Radiation Therapy Treatment Planning
News | Treatment Planning | January 31, 2019
January 31, 2019 — Philips announced a collaboration with imaging solutions provider MIM Software Inc.
Laurent Levy, CEO of Nanobiotix, explains the use of his company’s nanoparticles to enhance the radiation sensitivity of tumor tissue to improve patient outcomes

Laurent Levy, CEO of Nanobiotix, explains the use of his company’s nanoparticles to enhance the radiation sensitivity of tumor tissue to improve patient outcomes. The metallic-based nanoparticles show up on CT scans so it can be used as a permanent fiduciary marker to track tumor response. The images show the initial tumor and enhancement areas due to the nanoparticles and the resulting outcomes following treatment. Photo by Dave Fornell

Feature | Radiation Oncology | January 30, 2019 | By Dave Fornell
Artificial intelligence (AI) has been the hot topic discussed at all trade shows, and the...
Videos | Lung Cancer | January 29, 2019
Gregory Videtic, M.D., staff physician in radiation oncology at the Cleveland Clinic, and David Johnstone, M.D., prof
Southern Asia's First Proton Therapy Center Begins Treatments
News | Proton Therapy | January 28, 2019
IBA (Ion Beam Applications SA) announced the opening of the Apollo Proton Cancer Centre in Chennai, India, and the...